Kinase activity profiles computed from phosphoproteomic data


In recent years, advances in phosphoproteomics have significantly deepened our understanding of kinase-driven signaling pathways. However, the direct measurement of kinase activity in tumors has been challenging due to the complexity and variability of phosphorylation events. To address this, computational approaches such as kinase-substrate enrichment analysis (KSEA) have been developed, enabling the estimation of kinase activity from phosphoproteomic data. This update integrates kinase activity profiles computed from tumor-specific phosphoproteomic datasets, providing insights into the regulatory networks that govern cancer progression and treatment responses.

Kinase Activity Profiles

AbbreviationFull NameNumber of Tumor SamplesNumber of Normal SamplesTotal
CRC Colorectal Cancer 243 100 343
GBM Glioblastoma Multiforme 99 9 108
HCC Hepatocellular Carcinoma 103 103 206
HGSC High-Grade Serous Carcinoma 152 20 172
HNSCC Head and Neck Squamous Cell Carcinoma 108 172 280
LSCC Lung Squamous Cell Carcinoma 108 99 207
LUAD Lung Adenocarcinoma 110 101 211
PDAC Pancreatic Ductal Adenocarcinoma 140 67 207
UCEC Uterine Corpus Endometrial Carcinoma 104 49 153

Interactive Dot Plot with D3
AbbreviationFull NameNumber of Tumor Samples
AML Acute Myeloid Leukemia 74
BC Breast Cancer 419
CRC Colorectal Cancer 243
GBM Glioblastoma Multiforme 99
HCC Hepatocellular Carcinoma 103
HGSC High-Grade Serous Carcinoma 152
HNSCC Head and Neck Squamous Cell Carcinoma 108
iCCA intrahepatic Cholangiocarcinoma 214
LSCC Lung Squamous Cell Carcinoma 108
LUAD Lung Adenocarcinoma 110
PBC Primary Biliary Cholangitis 217
PDAC Pancreatic Ductal Adenocarcinoma 140
UCEC Uterine Corpus Endometrial Carcinoma 104

Interactive Dot Plot with D3

TOP